James Camakaris Selected Research

Prion Proteins

1/2009

Regulation of prion gene expression by transcription factors SP1 and metal transcription factor-1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

James Camakaris Research Topics

Disease

9	Alzheimer Disease (Alzheimer's Disease) 10/2014 - 05/2004
6	Menkes Kinky Hair Syndrome (Menkes Disease) 08/2010 - 10/2002
3	Hepatolenticular Degeneration (Wilson's Disease) 03/2007 - 11/2002
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2014 - 01/2005
2	Amyloid Plaque 04/2013 - 01/2008
1	Neuroblastoma 04/2014
1	Parkinson Disease (Parkinson's Disease) 01/2014
1	Motor Neuron Disease (Primary Lateral Sclerosis) 01/2014
1	Dementia (Dementias) 04/2013
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 01/2009

Drug/Important Bio-Agent (IBA)

16	CopperIBA 04/2014 - 10/2002
7	Proteins (Proteins, Gene)FDA Link 04/2014 - 10/2002
6	P-type ATPasesIBA 01/2007 - 10/2002
4	Amyloid (Amyloid Fibrils)IBA 10/2014 - 03/2011
4	Amyloid beta-PeptidesIBA 04/2013 - 05/2004
3	Peptides (Polypeptides)IBA 10/2014 - 01/2008
2	MetalsIBA 01/2014 - 04/2013
2	ZincIBA 04/2013 - 03/2011
2	PresenilinsIBA 01/2013 - 03/2011
2	Amyloid beta-Protein Precursor (Amyloid Protein Precursor)IBA 10/2004 - 05/2004
1	Glutamine (L-Glutamine)FDA Link 10/2014
1	Threonine (L-Threonine)FDA Link 04/2014
1	Clioquinol (Vioform)FDA Link 01/2014
1	IonophoresIBA 01/2014
1	Trace Elements (Biometals)IBA 01/2014
1	IronIBA 04/2013
1	tau Proteins (tau Protein)IBA 04/2013
1	Prion ProteinsIBA 01/2009
1	Protein Isoforms (Isoforms)IBA 01/2009
1	Amino Acids FDA Link 01/2008
1	Copper-Transporting ATPasesIBA 03/2007
1	Adenosine Triphosphatases (ATPase)IBA 11/2002
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 11/2002

Therapy/Procedure

2	Therapeutics 04/2013 - 01/2009